SP

Spok Holdings, Inc.

SPOKHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$139.7M
+1.5% YoY
Net Income
$15.9M
+6.1% YoY
EBITDA
$23.6M
-2.6% YoY
Free Cash Flow
$20.8M

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20CONFIRMED▼ Below MA1500.6% below MA150
▼ MACD Negative CrossoverHistogram -0.0332, negative momentum
Oct 19▼ MACD Negative CrossoverHistogram -0.0131, negative momentum
About Spok Holdings, Inc.

Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Valued at $215.5M, SPOK is a micro-cap name in its sector. Its products and services enhance workflows for clinicians and support administrative compliance.

Where SPOK stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, SPOK finished 0.57% below its 150-day moving average ($10.49) and 4.05% below its 200-day moving average ($10.87). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is SPOK overbought or oversold?

At the October 20, 2026 close, SPOK's RSI(14) was 50.7, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$215.5M
P/E (TTM)18.07
Fwd P/E12.26
EPS$0.57
Beta0.45
52W Change-37.1%
Dividend Yield12.14%
ROE8.4%
Analysis

With $16.6M in cash and $5.7M in debt, SPOK maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $20.8M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 8.4% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.7% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $134.5M (2022) to $139.7M (2025).

SPOK's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Spok Holdings, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms